Corpus Intelligence IC Memo — THE AROOSTOOK MEDICAL CENTER 2026-04-26 03:50 UTC
IC Memo — THE AROOSTOOK MEDICAL CENTER
Investment Committee Memorandum | ME | 34 beds | Grade C | EBITDA uplift $9.9M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

THE AROOSTOOK MEDICAL CENTER

CCN 200018 | AROOSTOOK, ME | 34 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

THE AROOSTOOK MEDICAL CENTER is a 34-bed suburban community hospital in AROOSTOOK, ME with $134.8M in net patient revenue and a -23.5% operating margin. The hospital serves a payer mix of 27.6% Medicare, 15.2% Medicaid, and 57.2% commercial.

Thesis: Turnaround. Our ML models identify $9.9M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -23.5% to -16.1% (+736bps).

Net Revenue HCRIS$134.8M
Current EBITDA COMPUTED$-31.7M
Operating Margin COMPUTED-23.5%
Occupancy HCRIS85.9%
Revenue / Bed COMPUTED$4.0M
Net-to-Gross HCRIS30.8%
Distress Probability ML38.6%

2. Market Context & Competitive Position

38
ME Hospitals
-8.3%
State Median Margin
24
Comparable Hospitals

ME has 38 Medicare-certified hospitals with a median operating margin of -8.3%. The target's margin of -23.5% places it below the state median. Among 24 size-comparable peers (17-68 beds), the median margin is -4.9%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (17-68), prioritizing same-state peers. 24 hospitals in the comp set.

HospitalStateBedsRevenueMargin
THE AROOSTOOK MEDICAL CENTER (Target)ME34$134.8M-23.5%
YORK HOSPITALME54$197.1M-3.6%
REDINGTON-FAIRVIEW GENERAL HOSME25$135.4M-3.6%
LINCOLNHEALTHME25$116.8M-0.9%
WALDO COUNTY GENERAL HOSPITALME25$115.4M-6.4%
FRANKLIN MEMORIAL HOSPITALME46$103.4M-17.3%
STEPHENS MEMORIAL HOSPITAL - CME25$100.5M4.2%
MAINE COAST MEMORIAL HOSPITALME45$98.0M-5.5%
MOUNT DESERT ISLAND HOSPITALME25$74.8M-10.8%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $9.9M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$2.8M+210bp18mo
Cost to Collect4.5%2.5%$2.7M+200bp12mo
Denial Rate Reduction12.0%6.5%$2.7M+198bp12mo
A/R Days Reduction5200.0%3800.0%$1.6M+122bp9mo
Clean Claim Rate88.0%96.0%$86K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$2.8M
Cost to Collect
$2.7M
Denial Rate Reduction
$2.7M
A/R Days Reduction
$1.6M
Clean Claim Rate
$86K
Total EBITDA Uplift$9.9M
Current EBITDA$-31.7M
+ RCM Uplift+$9.9M
Pro Forma EBITDA$-21.7M
Current Margin-23.5%
Pro Forma Margin-16.1%
WC Released (1x)$5.2M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-48.7M$-109.7M0.00x-100.0%
Base (11x exit)10.0x11.0x$-48.7M$-136.5M0.00x-100.0%
Bull Case9.0x11.0x$-43.9M$-119.6M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-43.9M$-143.4M0.00x-100.0%
Bear Case11.0x10.0x$-53.6M$-143.5M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-53.6M$-175.2M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 24 hospitals with 17-68 beds
  • Same-state prioritization (n=25)
  • Comp margins: P25=-9.5% / P50=-4.9% / P75=0.1%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.